Skip to main content
. 2013 Aug 29;8(8):e72630. doi: 10.1371/journal.pone.0072630

Figure 3. Antiretroviral drug resistance levels among the ART-failure individuals in the Yunnan province in 2010–2011.

Figure 3

Note: DRV/r, darunavir with ritonavir; LPV/r, lopinavir with ritonavir; TPV/r, tipranavir with ritonavir; ABC, abacavir; FTC, emtricitabine; ETR, etravirine; DLV, delavirdin.